Patent · US Active

Methods for enhancing the effect of EGCg on mitigating skeletal muscle loss

US9579347B2 · kind B2 · utility

2Cited by
4References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 4, 2013
Grant dateFeb 28, 2017
Priority date—
Expiry dateOct 4, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA23V2002/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are methods for enhancing the efficacy of epigallocatechin gallate (“EGCg”) in mitigating skeletal muscle loss in a subject. Providing EGCg to a subject in a nutritional composition reduces muscle protein degradation, thereby mitigating skeletal muscle loss in the subject. The combination of EGCg with zinc in a nutritional composition enhances the mitigating effect that EGCg has on muscle loss. Specifically, when used in combination, a nutritional composition containing both EGCg and zinc requires less EGCg to obtain the same mitigating effect that occurs in the same nutritional composition containing EGCg but no zinc.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.